Harbour Investments’s Amedisys AMED Stock Holding History

Harbour Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$197	–	3747
2025 Q2	$197	Buy	+2	New	+$189	﹤0.01%	3475
2023 Q1	–	Sell	-17	Closed	-$1.42K	–	3003
2022 Q4	$1.42K	Sell	17 -36	-68%	-$3.25K	﹤0.01%	2603
2022 Q3	$6K	Hold	53	–	–	﹤0.01%	2092
2022 Q2	$6K	Buy	+53	New	+$6.77K	﹤0.01%	2092
2021 Q4	$9K	Sell	53 -138	-72%	-$22.2K	﹤0.01%	1956
2021 Q3	$29K	Buy	191 +123	+181%	+$25.6K	﹤0.01%	2082
2021 Q2	$17K	Sell	68 -36	-35%	-$9.45K	﹤0.01%	2415
2021 Q1	$28K	Buy	+104	New	+$29.3K	﹤0.01%	2012

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Harbour Investments's AMED Position: Q3 2025 in Review

Harbour Investments sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2 shares — an estimated $197 sold.

Harbour Investments first reported a position in AMED in Q1 2021 and held it in 8 quarters. The position peaked at $29K in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Harbour Investments reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Harbour Investments sold 2 Amedisys shares in Q3 2025, an estimated $197.
Harbour Investments first reported a position in Amedisys in Q1 2021 and held it in 8 quarters.
Harbour Investments's Amedisys position peaked at $29K in Q3 2021.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Harbour Investments's 13F filing for Q3 2025, filed 12 Nov 2025.